MedReleaf Corp. (TSX:LEAF) announced this morning that the company has entered into an partnership with Cannamedical Pharma GMBH to supply medical, MedReleaf branded, cannabis products to distribute to a collection of 1,800 pharmacies in Germany.
MedReleaf will begin sending product to Cannamedical Pharma GMBH once the company’s European Medical Agency Good Manufacturing Practices (“GMP”) certification and export permit from Health Canada are obtained in the next coming weeks.
MedReleaf Corporation will export five of its “premium stain” collections which will significantly improve upon the consistency of cannabis products distributed in Germany. Germany will rely on cannabis exports to meet the growing demand of products in the country.
“Federally legal markets for cannabis outside Canada are by and large focused on medical applications. This plays to MedReleaf’s core strengths in R&D, innovation, quality control, and pharmaceutical grade standards,” said Neil Closner, President and CEO. “Medical cannabis in Germany has been in short supply and Cannamedical is an ideal partner to bring MedReleaf’s premium cannabis products into Germany as one of Europe’s leading cannabis distributors with shared values on patient-centricity, a proven track record, and a growing network of 1,800 pharmacies.”
You may be interested
Nevada Sold $35M of Recreational Cannabis in February 2018Sam Rosenberg - April 25, 2018
Nevada's recreational cannabis stores netted a total of $35M in total sales over the month of February. The state has generated a total of $6M in taxes…
Oklahoma governor signs industrial hemp legislationSam Rosenberg - April 25, 2018
OKLAHOMA CITY (AP) — The Oklahoma governor has signed into law a measure allowing universities and farmers who work them to grow industrial hemp. The Tulsa World…
Organigram Holdings Announces $3.7M in Revenue for Q2 FinancialsSam Rosenberg - April 24, 2018
Organigram Holdings (TSX VENTURE: OGI) (OTCQB:OGRMF) announced this morning that the company has netted approximately $3.7M in revenue for its second quarter financials. This is company's best quarter…